Phase I/II trial of vandetanib and bortezomib in adults with locally advanced or metastatic medullary thyroid cancer: Phase I results.

被引：3
|
作者：
Gramza, A. W. [1 ]
Wells, S. A. [1 ]
Balasubramaniam, S. [1 ]
Fojo, A. T. [1 ]
机构：
[1] NCI, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5565
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5565
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
    Sullivan, Ryan J.
    Ibrahim, Nageatte
    Lawrence, Donald P.
    Aldridge, Julie
    Giobbie-Hurder, Anita
    Hodi, F. Stephen
    Flaherty, Keith T.
    Conley, Christine
    Mier, James W.
    Atkins, Michael B.
    McDermott, David F.
    ONCOLOGIST, 2015, 20 (06): : 617 - 618
  • [42] A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma
    de Groot, J. W. B.
    Zonnenberg, B. A.
    van Ufford-Mannesse, P. Quarles
    de Vries, M. M.
    Links, T. P.
    Lips, C. J. M.
    Voest, E. E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (09): : 3466 - 3469
  • [43] A phase I/II study of the MEK inhibitor BAY 86-9766 (BAY) in combination with gemcitabine (GEM) in patients with nonresectable, locally advanced or metastatic pancreatic cancer (PC): Phase I dose-escalation results.
    Van Laethem, Jean-Luc
    Heinemann, Volker
    Martens, Uwe Marc
    Jassem, Jacek
    Michl, Patrick
    Peeters, Marc
    Weekes, Colin D.
    Marechal, Raphael
    Stieler, Jens
    Giurescu, Marius
    Rajagopalan, Prabhu
    Garosi, Vittorio Luigi
    Riess, Hanno
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial
    Li, Dapeng
    Chi, Yihebali
    Chen, Xiaohong
    Ge, Minghua
    Zhang, Yuan
    Guo, Zhuming
    Wang, Jun
    Chen, Jie
    Zhang, Jiewu
    Cheng, Ying
    Li, Zhendong
    Liu, Hui
    Qin, Jianwu
    Zhu, Jingqiang
    Cheng, Ruochuan
    Xu, Zhengang
    Zheng, Xiangqian
    Tang, Pingzhang
    Gao, Ming
    CLINICAL CANCER RESEARCH, 2021, 27 (13) : 3567 - 3575
  • [45] A phase I trial of S-I with concurrent radiotherapy for locally advanced pancreatic cancer
    Ikeda, M.
    Okusaka, T.
    Ito, Y.
    Ueno, H.
    Morizane, C.
    Furuse, J.
    Ishii, H.
    Kawashima, M.
    Kagami, Y.
    Ikeda, H.
    BRITISH JOURNAL OF CANCER, 2007, 96 (11) : 1650 - 1655
  • [46] A phase I study of vandetanib and metronomic chemotherapy in advanced breast cancer
    Mayer, E. L.
    Isakoff, S. J.
    Hannagan, K.
    Savoie, J.
    Beckman, J.
    Klement, G.
    Gelman, R.
    Winer, E. P.
    Burstein, H. J.
    CANCER RESEARCH, 2009, 69 (02) : 105S - 105S
  • [47] Neoadjuvant chemoradiotherapy (NACRT) in patients with locally advanced rectal cancer (RC): Results of a phase I/II trial in Japan.
    Koyama, Takafumi
    Gomi, Daisuke
    Yukinori, Ozaki
    Nakamura, Yoshiaki
    Nagano, Masafumi
    Mike, Makio
    Kano, Nobuyuki
    Oyama, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [48] Mature results of a phase I trial of bortezomib, cisplatin, and radiotherapy for advanced or recurrent head and neck cancer.
    Axelrod, R. S.
    Ahn, P. H.
    Kubicek, G. J.
    Anne, P. R.
    Cognetti, D.
    Dicker, A.
    Machtay, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Phase II trial of sunitinib in medullary thyroid cancer (MTC)
    De Souza, J. A.
    Busaidy, N.
    Zimrin, A.
    Seiwert, T. Y.
    Villaflor, V. M.
    Poluru, K. B.
    Reddy, P. L.
    Nam, J.
    Vokes, E. E.
    Cohen, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Neoadjuvant radiochemotherapy for locally advanced gastric cancer:: Long-term results of a phase I trial
    Allal, AS
    Zwahlen, D
    Bründler, MA
    De Peyer, R
    Morel, P
    Huber, O
    Roth, AD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (05): : 1286 - 1289
12345